Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Michael Dougherty
Advertisement
Articles by Michael Dougherty
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
AI has Redefined Healthcare Communication — and There’s No Opting Out
2
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
3
FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer
4
Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals
5